CINRYZE® (C1 esterase inhibitor [human]) is an injectable prescription medicine that is used to help prevent swelling and/or painful attacks in children (6 years of age and older), teenagers and adults with Hereditary Angioedema (HAE).
OnePath is a free product support program that can help eligible patients who have been prescribed CINRYZE per the approved indication gain access to their medication. Once CINRYZE® (C1 esterase inhibitor [human]) has been prescribed to you and you have enrolled in OnePath, you will be connected with a dedicated Patient Support Manager (PSM) who will work with you to help you get access to your medication, in addition to providing other product support services.
Help with facilitating an insurance benefits investigation, and explaining insurance coverage and financial assistance options (if applicable)
In-home administration training and support for you and your caregiver(s) at no cost
Educational resources and the OnePath Mobile App for you and your caregiver(s) at no cost
Resources specifically tailored for caregivers to give them the information and support needed to make informed decisions about the health of those they care for
Patients enrolled in OnePath may use the OnePath Mobile App to connect with OnePath and track their health in a personal eDiary.
Do not try to self-administer CINRYZE until a healthcare professional has taught you or a caregiver how.
Are you ready to learn how to self-administer?
Learn more about the Path to Independence™ Program.